Go Pro

Avalyn Pharma (AVLN) Earnings Date, Estimates & Call Transcripts

Avalyn Pharma logo
$33.92 0.00 (0.00%)
As of 08/7/2026 04:00 PM Eastern

Avalyn Pharma Earnings Summary

Avalyn Pharma released Q1 2026 earnings on June 3, 2026, reporting an EPS of -$21.83, which missed the consensus estimate of -$16.38 by $5.45. With a trailing EPS of -$21.83, Avalyn Pharma's earnings are expected to grow next year, from ($3.45) to ($1.78) per share.

Consensus EPS
(Jun. 3)
-$16.38
Actual EPS
(Jun. 3)
-$21.83 Missed By -$5.45

Q1 2026 Earnings Resources

Get Avalyn Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avalyn Pharma and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Avalyn Pharma Analyst EPS Estimates

Current Year EPS Consensus Estimate
($3.45) EPS
Next Year EPS Consensus Estimate
($1.78) EPS

Avalyn Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
6/3/2026Q1 2026-$16.38-$21.83 -$5.45-$21.83--

Avalyn Pharma Earnings - Frequently Asked Questions

Avalyn Pharma (NASDAQ:AVLN) last announced its quarterly earning data on Wednesday, June 3, 2026. Learn more on AVLN's earnings history.

In the previous quarter, Avalyn Pharma (NASDAQ:AVLN) missed the analysts' consensus estimate of ($16.38) by $5.45 with a reported earnings per share (EPS) of ($21.83). Learn more on analysts' earnings estimate vs. AVLN's actual earnings.

Avalyn Pharma's earnings are expected to grow from ($3.45) per share to ($1.78) per share in the next year.


Earnings data for NASDAQ:AVLN is sourced from Fiscal.ai, with the most recent quarter reported on 6/3/2026. New results are added as companies report their earnings.
From Our Partners